KMDA
Kamada
NASDAQ: KMDA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$8.00
-0.62% today
Updated 2026-10-28
Market cap
$448.41M
P/E ratio
20.45
P/S ratio
2.34x
EPS (TTM)
$0.38
Dividend yield
2.19%
52W range
$6 – $9
Volume
0.1M
Kamada (KMDA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$8.00
12-Month target
$7.06
2030 Target
$11.18
Intrinsic (DCF)
$9.81
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 6.25% (capped 20%) · P/E: 20.45x (capped 25x) · Margin: 11.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.